These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1222 related articles for article (PubMed ID: 1370679)
1. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679 [TBL] [Abstract][Full Text] [Related]
2. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. Koulova L; Clark EA; Shu G; Dupont B J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724 [TBL] [Abstract][Full Text] [Related]
3. Functional expression of B7/BB1 on activated T lymphocytes. Azuma M; Yssel H; Phillips JH; Spits H; Lanier LL J Exp Med; 1993 Mar; 177(3):845-50. PubMed ID: 7679711 [TBL] [Abstract][Full Text] [Related]
4. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. Harding FA; Allison JP J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody. Makrigiannis AP; Musgrave BL; Hoskin DW J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511 [TBL] [Abstract][Full Text] [Related]
6. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes. de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643 [TBL] [Abstract][Full Text] [Related]
7. Requirements for CD28-dependent T cell-mediated cytotoxicity. Azuma M; Cayabyab M; Phillips JH; Lanier LL J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716 [TBL] [Abstract][Full Text] [Related]
8. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475 [TBL] [Abstract][Full Text] [Related]
9. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Carabasi MH; DiSanto JP; Yang SY; Dupont B Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547 [TBL] [Abstract][Full Text] [Related]
10. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325 [TBL] [Abstract][Full Text] [Related]
11. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. Van Gool SW; de Boer M; Ceuppens JL J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237 [TBL] [Abstract][Full Text] [Related]
12. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116 [TBL] [Abstract][Full Text] [Related]
13. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111 [TBL] [Abstract][Full Text] [Related]
14. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624 [TBL] [Abstract][Full Text] [Related]
16. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946 [TBL] [Abstract][Full Text] [Related]
17. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031 [TBL] [Abstract][Full Text] [Related]
18. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725 [TBL] [Abstract][Full Text] [Related]
19. A comparative assessment of the roles of CD8 and CD2 in the functions of activated murine CD8+ T lymphocytes. Reimann A; Ehrfeld A; Kupsch J; Maier B; Saizawa KM; Clinchy B; Eichmann K Immunol Lett; 1991 Oct; 30(2):149-58. PubMed ID: 1684570 [TBL] [Abstract][Full Text] [Related]
20. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules. de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]